1. Balteau, E., Tabelow, K., Ashburner, J., Callaghan, M.F., Draganski, B., Helms, G., Kherif, F., Leutritz, T., Lutti, A., Phillips, C., Reimer, E., Ruthotto, L., Seif, M., Weiskopf, N., Ziegler, G., and Mohammadi, S. (2018). hMRI -- A toolbox for using quantitative MRI in neuroscience and clinical research. Weierstraß-Institut für Angewandte Analysis und Stochastik Leibniz-Institut im Forschungsverbund Berlin e. V. Berlin. 10.20347/WIAS.PREPRINT.2527
2. Bartzokis, G (2004). Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging, 25 (2004), pp. 5-18
3. Callaghan, M. F., P. Freund, B. Draganski, E. Anderson, M. Cappelletti, R. Chowdhury, J. Diedrichsen, T. H. B. Fitzgerald, P. Smittenaar, G. Helms, A. Lutti, and N. Weiskopf (2014). “Widespread age related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging.” Neurobiol. Aging 35.8, pp. 1862–1872.
4. Dean, D. C. III, Hurley, S.A., Kecskemeti, S.R., O’Grady, J.P., Canda, C., Davenport-Sis, N.J., Zetterberg, H., Blennow, K., Asthana, S., Sager, M.A., Johnson, S.C., Alexander, A.L. and Bendelin, B.B (2017). Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol; 74:41–9.